Basiri H, Kiura K, DeNardin E G, Nakamura I
Department of Pathology, School of Medicine and Biomedical Sciences, State University of New York at Buffalo 14214, USA.
J Immunol. 1995 Sep 15;155(6):2822-32.
More than 90% of IL-2-activated plastic-adherent murine splenocytes (A-LAK4 cells) are NK1.1+ NK cells and both H-2b/b homozygous C57BL/6- and H-2b/d heterozygous (C57BL/6 x DBA/2)F1 (B6D2F1)-derived populations of such cells contain an Ly-49A+ subset. In B6D2F1 A-LAK cells, as well as in freshly isolated spleen cells of the same mice, Ly-49A+ cells represent approximately 10% of NK1.1+ cells. However, the level of Ly-49A expression in B6D2F1 NK cells is lower than in C57BL/6 (B6). The cytolytic activity of B6- and B6D2F1-derived A-LAK cells against normal target cells is specific, and is in agreement with the known patterns of natural resistance in vivo against Hh-1-mismatched bone marrow allografts. H-2b lymphoma cells transfected with the Dd gene, but not the Ld gene, no longer express the Hh-1b phenotype that is recognized by B6D2F1 A-LAK cells, raising the possibility that this selective effect of the Dd gene on Hh-1b phenotype is related to the known inability of Ly-49A+ A-LAK cells to kill Dd-expressing tumor target cells. Depletion of Ly-49A+ A-LAK cells by Ab and complement reduces the lytic capacity of B6D2F1 A-LAK cells against normal B6 target cells of the Hh-1b phenotype to one-third of the original level. Conversely, positively selected Ly-49A+ A-LAK cells are enriched for the same activity. The results, therefore, favor the view that the Hh-1 phenotype of the target cells may be defined largely by the effector cell's recognition of class I Ags on the target cell surface.
超过90%的白细胞介素2激活的贴壁小鼠脾细胞(A-LAK4细胞)是NK1.1+自然杀伤细胞,并且来自H-2b/b纯合的C57BL/6小鼠以及H-2b/d杂合(C57BL/6×DBA/2)F1(B6D2F1)小鼠的这类细胞群体均包含Ly-49A+亚群。在B6D2F1 A-LAK细胞以及同一小鼠新鲜分离的脾细胞中,Ly-49A+细胞约占NK1.1+细胞的10%。然而,B6D2F1自然杀伤细胞中Ly-49A的表达水平低于C57BL/6(B6)小鼠中的表达水平。源自B6和B6D2F1小鼠的A-LAK细胞对正常靶细胞的细胞溶解活性具有特异性,并且与体内已知的针对Hh-1不匹配骨髓同种异体移植的天然抗性模式一致。用Dd基因而非Ld基因转染的H-2b淋巴瘤细胞不再表达被B6D2F1 A-LAK细胞识别的Hh-1b表型,这增加了Dd基因对Hh-1b表型的这种选择性作用与已知的Ly-49A+ A-LAK细胞无法杀伤表达Dd的肿瘤靶细胞有关的可能性。用抗体和补体去除Ly-49A+ A-LAK细胞会使B6D2F1 A-LAK细胞对Hh-1b表型的正常B6靶细胞的溶解能力降低至原始水平的三分之一。相反,经阳性选择的Ly-49A+ A-LAK细胞的这种活性得到增强。因此,这些结果支持这样一种观点,即靶细胞的Hh-1表型可能在很大程度上由效应细胞对靶细胞表面I类抗原的识别所决定。